New

Asia Pacific Pharmaceutical Isolator Market

2021

Asia Pacific Pharmaceutical Isolator Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Open Isolator and Closed Isolator), Pressure (Positive Pressure and Negative Pressure), Configuration (Floor Standing, Modular, Mobile, and Compact), Application (Aseptic Isolators, Containment Isolators, Sampling and Weighing Isolators, Fluid Dispensing Isolators, and Others), and End User (Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Laboratories, and Others)

Publication Month: Nov 2021 | Report Code: TIPRE00025883 | No. of Pages: 160 | Category: Pharmaceuticals | Status: Published

Market Insights

Asia Pacific Pharmaceutical Isolator Market to Grow at a CAGR of 9.3% to reach US$ 1,975.83 million by 2028 Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The APAC pharmaceutical isolator market is expected to grow from US$ 1,060.82 million in 2021 to US$ 1,975.83 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2021 to 2028.


China, India, Japan, South Korea, and Australia are major economies in APAC. Burgeoning adoption of automation in pharmaceutical isolator is expected to fuel the market growth. In the pharmaceutical industry. automation of aseptic procedures, with the help of dedicated workstations and system software, has lowered manual interference in manufacturing processes, increased efficiency, and enabled researchers to concentrate on important tasks and avoid human errors. The increased adoption of automated pharmaceutical isolators can also be attributed to factors such as maintaining stringent regulatory compliance, increasing efficiency and productivity, and driving the safety and integrity of pharmaceutical products. The advancement of automation, including robotics, is one area of progress for aseptic fill-finish processes. Recent emerging technologies in aseptic processing, such as advanced isolators, robotics, and increased automation, are expected to change the industry and markedly reduced contamination risks for sterile products. Conventional isolator systems routinely require many operators at a time when regulators have long stated the need for aseptic filling systems to use robotics and reduce human interaction in drug manufacturing. Gloveless isolator technology for biopharmaceutical processes is getting traction in the industry. Future trends in technology are making isolators increasingly attractive for aseptic operations. Automated isolators are a perfect fit for parenteral solution products that can ensure the highest level of aseptic conditions. Therefore, growing use of automation is expected to fuel the APAC market growth.

In case of COVID-19, APAC is highly affected specially India. The APAC biopharmaceutical industry has been disturbed for few months of 2020 during the outbreak of the COVID-19 pandemic. However, with the rising demand for products to treat the COVID-19 infection, the biopharmaceutical, and pharmaceutical companies in the countries such as India and China have increased their production of APIs as the countries are the largest exporters to western companies. For instance, Wockhardt Ltd is in talks with the Indian government to offer its sterile development facility for the covid-19 vaccines that will be developed in the country, as well as with some firms whose vaccines are currently in phase I/II trials globally. Moreover, on 07 May 2020, Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services with sites in Belgium, United States, Japan, and India, announced it has entered into a manufacturing services agreement with CytoDyn Inc., a late-stage biotechnology company, for the supply of the investigational new drug, leronlimab (PRO 140), which is currently being used in clinical trial protocols for Mild-to-Moderately Ill and Severely Ill COVID-19 patients. The countries are experiencing growth in biologics production also; there is growth in the contract manufacturing for biopharmaceutical and pharmaceutical products. For instance, in January 2020, STA Pharmaceutical Co., Ltd. (WuXi AppTec) has expanded its oligonucleotide API manufacturing in China. Similarly, companies have engaged in the production of vaccines and have sent them to clinical trials. For instance, in Japan, Gilead's Remdesivier and Fujifilm's antiviral Avigan are in Phase III clinical trials. Thus, with the growing production by the biopharmaceutical industry, the pharmaceutical isolators market is likely to have vital growth opportunities in the following years.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC pharmaceutical isolator market. The APAC pharmaceutical isolator market is expected to grow at a good CAGR during the forecast period.
APAC pharmaceutical isolator market

Get more information on this report :


APAC Pharmaceutical Isolator Market Segmentation

APAC Pharmaceutical Isolator Market – By Type

  • Open Isolators
  • Closed Isolators

APAC Pharmaceutical Isolator Market – By Pressure

  • Positive Pressure
  • Negative Pressure

APAC Pharmaceutical Isolator Market – By Configuration

  • Floor Standing
  • Modular
  • Compact
  • Mobile

APAC Pharmaceutical Isolator Market – By Application

  • Aseptic
  • Sampling & Weighing
  • Fluid Dispensing
  • Containment
  • Others

APAC Pharmaceutical Isolator Market – By End User

  • Pharmaceutical and Biotechnology Companies
  • Hospitals
  • Research and Academic Laboratories
  • Other

APAC Pharmaceutical Isolator Market, by Country

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

APAC Pharmaceutical Isolator Market -Companies Mentioned

  • Azbil Telstar
  • Bioquell (Ecolab Solution)
  • Comecer
  • Fedegari Autoclavi S.p.A.
  • Gelman Singapore
  • Getinge AB
  • Hosokawa Micron Group
  • Nuaire Inc.
  • Schematic Engineering Industries

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Pharmaceutical Isolator Market – By Type

1.3.2 APAC Pharmaceutical Isolator Market – By Pressure

1.3.3 APAC Pharmaceutical Isolator Market – By Configuration

1.3.4 APAC Pharmaceutical Isolator Market – By Application

1.3.5 APAC Pharmaceutical Isolator Market – By End User

1.3.6 APAC Pharmaceutical Isolator Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Pharmaceutical Isolator Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging investments by Pharmaceutical and Biotechnology Industry

5.1.2 Structure to Support Adoption of Pharmaceutical Isolators

5.2 Market Restraint

5.2.1 Overpriced Operation and Maintenance

5.3 Market Opportunities

5.3.1 Escalating Pharmaceutical and Biotechnological Industries

5.4 Future Trends

5.4.1 Burgeoning Adoption of Automation in Pharmaceutical Isolator

5.5 Impact Analysis

6. Pharmaceutical Isolator Market – APAC Analysis

6.1 APAC Pharmaceutical Isolator Market Revenue Forecast and Analysis

7. APAC Pharmaceutical Isolator Market Analysis and forecasts to 2028 –By Type

7.1 Overview

7.2 APAC Pharmaceutical Isolator Market Share by Type 2021 & 2028 (%)

7.3 Open Isolator

7.3.1 Overview

7.3.2 Open Isolator Market Revenue and Forecast to 2028 (US$ Mn)

7.4 Closed Isolator

7.4.1 Overview

7.4.2 Closed Isolator Market Revenue and Forecast to 2028 (US$ Mn)

8. APAC Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By Pressure

8.1 Overview

8.2 APAC Pharmaceutical Isolator Market Share by Pressure 2021 & 2028 (%)

8.3 Positive Pressure

8.3.1 Overview

8.3.2 Positive Pressure Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Negative Pressure

8.4.1 Overview

8.4.2 Negative Pressure Market Revenue and Forecast to 2028 (US$ Mn)

9. APAC Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By Configuration

9.1 Overview

9.2 APAC Pharmaceutical Isolator Market Share by Configuration 2021 & 2028 (%)

9.3 Floor Standing

9.3.1 Overview

9.3.2 Floor Standing Market Revenue and Forecast to 2028 (US$ Mn)

9.4 Modular

9.4.1 Overview

9.4.2 Modular Market Revenue and Forecast to 2028 (US$ Mn)

9.5 Compact

9.5.1 Overview

9.5.2 Compact Market Revenue and Forecast to 2028 (US$ Mn)

9.6 Mobile

9.6.1 Overview

9.6.2 Mobile Market Revenue and Forecast to 2028 (US$ Mn)

10. APAC Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By Application

10.1 Overview

10.2 APAC Pharmaceutical Isolator Market Share by Application 2021 & 2028 (%)

10.3 Aseptic Isolators

10.3.1 Overview

10.3.2 Aseptic Isolators Market Revenue and Forecast to 2028 (US$ Mn)

10.4 Sampling and Weighing Isolators

10.4.1 Overview

10.4.2 Sampling and Weighing Isolators Market Revenue and Forecast to 2028 (US$ Mn)

10.5 Fluid Dispensing Isolators

10.5.1 Overview

10.5.2 Fluid Dispensing Isolators Market Revenue and Forecast to 2028 (US$ Mn)

10.6 Containment Isolators

10.6.1 Overview

10.6.2 Containment Isolators Market Revenue and Forecast to 2028 (US$ Mn)

10.7 Others

10.7.1 Overview

10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

11. APAC Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By End User

11.1 Overview

11.2 APAC Pharmaceutical Isolator Market Share by End User 2021 & 2028 (%)

11.3 Pharmaceuticals and Biotechnology Companies

11.3.1 Overview

11.3.2 Pharmaceutical And Biotechnology Market Revenue and Forecast to 2028 (US$ Mn)

11.4 Hospitals

11.4.1 Overview

11.4.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)

11.5 Research and Academic Laboratories

11.5.1 Overview

11.5.2 Research and Academic Laboratories Market Revenue and Forecast to 2028 (US$ Mn)

11.6 Others

11.6.1 Overview

11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

12. APAC Pharmaceutical Isolator Market – Country Analysis

12.1 APAC: Pharmaceutical Isolator Market

12.1.1 Overview

12.1.2 APAC: Pharmaceutical Isolator Market, by Country, 2021 & 2028 (%)

12.1.2.1 China: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.1 China: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.2 China: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.3 China: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.4 China: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.5 China: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)

12.1.2.1.6 China: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

12.1.2.2 Japan: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.1 Japan: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.2 Japan: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.3 Japan: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.4 Japan: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.5 Japan: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)

12.1.2.2.6 Japan: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

12.1.2.3 India: Pharmaceutical Isolator Market - Revenue and Forecasts to 2028 (USD Million)

12.1.2.3.1 India: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.2 India: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.3 India: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.4 India: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.5 India: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)

12.1.2.3.6 India: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

12.1.2.4 South Korea: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.4.1 South Korea: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.4.2 South Korea: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

12.1.2.4.3 South Korea: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

12.1.2.4.4 South Korea: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

12.1.2.4.5 South Korea: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)

12.1.2.4.6 South Korea: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

12.1.2.5 Australia: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.5.1 Australia: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.5.2 Australia: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

12.1.2.5.3 Australia: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

12.1.2.5.4 Australia: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

12.1.2.5.5 Australia: Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)

12.1.2.5.6 Australia: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

12.1.2.6 Rest of APAC: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.6.1 Rest of APAC: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.6.2 Rest of APAC: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

12.1.2.6.3 Rest of APAC: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

12.1.2.6.4 Rest of APAC: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

12.1.2.6.5 Rest of APAC: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)

12.1.2.6.6 Rest of APAC: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

13. Impact of COVID-19 Pandemic on APAC Pharmaceutical Isolator Market

13.1 APAC: Impact Assessment of COVID-19 Pandemic

14. Industry Landscape

14.1 Overview

14.2 Organic Developments

14.2.1 Overview

14.3 Inorganic Developments

14.3.1 Overview

15. Company Profiles

15.1 Schematic Engineering Industries

15.1.1 Key Facts

15.1.2 Business Description

15.1.3 Products and Services

15.1.4 Financial Overview

15.1.5 SWOT Analysis

15.1.6 Key Developments

15.2 Nuaire Inc.

15.2.1 Key Facts

15.2.2 Business Description

15.2.3 Products and Services

15.2.4 Financial Overview

15.2.5 SWOT Analysis

15.2.6 Key Developments

15.3 Comecer

15.3.1 Key Facts

15.3.2 Business Description

15.3.3 Products and Services

15.3.4 Financial Overview

15.3.5 SWOT Analysis

15.3.6 Key Developments

15.4 Getinge AB

15.4.1 Key Facts

15.4.2 Business Description

15.4.3 Products and Services

15.4.4 Financial Overview

15.4.5

15.4.6 SWOT Analysis

15.4.7 Key Developments

15.5 Hosokawa Micron Group

15.5.1 Key Facts

15.5.2 Business Description

15.5.3 Products and Services

15.5.4 Financial Overview

15.5.5 SWOT Analysis

15.5.6 Key Developments

15.6 Fedegari Autoclavi S.p.A.

15.6.1 Key Facts

15.6.2 Business Description

15.6.3 Products and Services

15.6.4 Financial Overview

15.6.5 SWOT Analysis

15.6.6 Key Developments

15.7 Azbil Telstar

15.7.1 Key Facts

15.7.2 Business Description

15.7.3 Products and Services

15.7.4 Financial Overview

15.7.5 SWOT Analysis

15.7.6 Key Developments

15.8 Gelman Singapore

15.8.1 Key Facts

15.8.2 Business Description

15.8.3 Products and Services

15.8.4 Financial Overview

15.8.5 SWOT Analysis

15.8.6 Key Developments

15.9 Bioquell ( Ecolab Solution)

15.9.1 Key Facts

15.9.2 Business Description

15.9.3 Products and Services

15.9.4 Financial Overview

15.9.5 SWOT Analysis

15.9.6 Key Developments

16. Appendix

16.1 About The Insight Partners

16.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

Table 2. China Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

Table 3. China Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

Table 4. China Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

Table 5. China Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)

Table 6. China Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

Table 7. Japan Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

Table 8. Japan Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

Table 9. Japan Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

Table 10. Japan Pharmaceutical Isolator Market , by Application, – Revenue and Forecast to 2028 (USD Million)

Table 11. Japan Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. India: R&D spending of Pharmaceutical companies (2010 & 2017)

Table 13. India Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

Table 14. India Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

Table 15. India Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

Table 16. India Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)

Table 17. India Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

Table 18. South Korea Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

Table 19. South Korea Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

Table 20. South Korea Pharmaceutical Isolator Market , by Configuration– Revenue and Forecast to 2028 (USD Million)

Table 21. South Korea Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)

Table 22. South Korea Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

Table 23. Australia Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

Table 24. Australia Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

Table 25. Australia Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

Table 26. Australia Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)

Table 27. Australia Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

Table 28. Rest of APAC Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

Table 29. Rest of APAC Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

Table 30. Rest of APAC Pharmaceutical Isolator Market , by configuration – Revenue and Forecast to 2028 (USD Million)

Table 31. Rest of APAC Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)

Table 32. Rest of APAC Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

Table 33. Organic Developments Done By Companies

Table 34. Inorganic Developments Done by Companies

Table 35. Glossary of Terms

LIST OF FIGURES

Figure 1. APAC Pharmaceutical Isolator Market Segmentation

Figure 2. APAC Pharmaceutical Isolator Market Segmentation, By Country

Figure 3. APAC Pharmaceutical Isolator Market Overview

Figure 4. Open Isolators Segment led the Market in 2021

Figure 5. India to Show Significant Growth During Forecast Period

Figure 6. APAC PEST Analysis

Figure 7. APAC Pharmaceutical Isolator Market Impact Analysis of Driver and Restraints

Figure 8. APAC Pharmaceutical Isolator Market – Revenue Forecast and Analysis

Figure 9. APAC Pharmaceutical Isolator Market Share by Type 2021 & 2028 (%)

Figure 10. APAC Open Isolator Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. APAC Closed Isolator Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. APAC Pharmaceutical Isolator Market Share by Pressure 2021 & 2028 (%)

Figure 13. APAC Positive Pressure Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. APAC Negative Pressure Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. APAC Pharmaceutical Isolator Market Share by Configuration 2021 & 2028 (%)

Figure 16. APAC Floor Standing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. APAC Modular Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. APAC Compact Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. APAC Mobile Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. APAC Pharmaceutical Isolator Market Share by Application 2021 & 2028 (%)

Figure 21. APAC Aseptic Isolators Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. APAC Sampling and Weighing Isolators Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. APAC Fluid Dispensing Isolators Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. APAC Containment Isolators Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. APAC Others Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. APAC Pharmaceutical Isolator Market Share by End User 2021 & 2028 (%)

Figure 27. APAC Pharmaceutical and Biotechnology Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. APAC Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. APAC Research and Academic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30. APAC Others Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31. APAC: Pharmaceutical Isolator Market, by Key Country – Revenue (2021) (USD Million)

Figure 32. APAC: Pharmaceutical Isolator Market, by Country, 2021 & 2028 (%)

Figure 33. China Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Japan: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

Figure 35. India: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

Figure 36. South Korea: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

Figure 37. Australia: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

Figure 38. Rest of APAC: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

Figure 39. Impact of COVID-19 Pandemic in APAC Country Markets

  1. Azbil Telstar
  2. Bioquell (Ecolab Solution)
  3. Comecer
  4. Fedegari Autoclavi S.p.A.
  5. Gelman Singapore
  6. Getinge AB
  7. Hosokawa Micron Group
  8. Nuaire Inc.
  9. Schematic Engineering Industries
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC pharmaceutical isolator market.   
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in APAC pharmaceutical isolator market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the pharmaceutical isolator market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution       
TIPRE00025883
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.